Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
Ophthalmology
|
March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A Wells, Adam R Glassman, Allison R Ayala, et al.
Ophthalmology
|
February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40
Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA
|
December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Andrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology
|
March 20, 2010
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction
, Julia A Haller, Haijing Qin, et al.
JAMA
|
May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA Ophthalmology
|
March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA
|
February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
December 13, 2006
Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema
, Ronald P Danis, Adam R Glassman, et al.
Ophthalmology
|
April 30, 2010
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
, Michael J Elman, Lloyd Paul Aiello, et al.
Ophthalmology
|
August 5, 2008
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema
David J Browning, Adam R Glassman, Lloyd P Aiello, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
Ophthalmology
|
March 4, 2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A Wells, Adam R Glassman, Allison R Ayala, et al.
Ophthalmology
|
February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40
Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA
|
December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Andrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology
|
March 20, 2010
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction
, Julia A Haller, Haijing Qin, et al.
JAMA
|
May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
JAMA Ophthalmology
|
March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA
|
February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
December 13, 2006
Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema
, Ronald P Danis, Adam R Glassman, et al.
Ophthalmology
|
April 30, 2010
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
, Michael J Elman, Lloyd Paul Aiello, et al.
Ophthalmology
|
August 5, 2008
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema
David J Browning, Adam R Glassman, Lloyd P Aiello, et al.
Page
of 13